Literature DB >> 20848537

The struggle within: microbial influences on colorectal cancer.

Janelle C Arthur1, Christian Jobin.   

Abstract

Recently, an unprecedented effort has been directed at understanding the interplay between chronic inflammation and development of cancer, with the case of inflammatory bowel disease (IBD)-associated colorectal cancer at the forefront of this research endeavor. The last decade has been particularly fertile, with the discovery of numerous innovative paradigms linking various inflammatory, proliferative, and innate and adaptive immune signaling pathways to the development of colorectal cancer. Because of the preponderant role of the intestinal microbiota in the initiation and progression of IBD, recent efforts have been directed at understanding the relationship between bacteria and colorectal cancer. The microbiota and its collective genome, the microbiome, form a diverse and complex ecological community that profoundly impacts intestinal homeostasis and disease states. This review will discuss the differential influence of the microbiota on the development of IBD-associated colorectal cancer and highlight the role of innate immune sensor-dependent as well as -independent mechanisms in this pathology.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20848537      PMCID: PMC3376405          DOI: 10.1002/ibd.21354

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  237 in total

1.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Viable bacteria present within oral squamous cell carcinoma tissue.

Authors:  Samuel J Hooper; St John Crean; Michael A O Lewis; David A Spratt; William G Wade; Melanie J Wilson
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 4.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

Review 5.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

6.  Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats.

Authors:  B L Pool-Zobel; B Bertram; M Knoll; R Lambertz; C Neudecker; U Schillinger; P Schmezer; W H Holzapfel
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

Review 7.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

Review 8.  Microbial community profiling for human microbiome projects: Tools, techniques, and challenges.

Authors:  Micah Hamady; Rob Knight
Journal:  Genome Res       Date:  2009-04-21       Impact factor: 9.043

9.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  47 in total

1.  The emerging medical ecology of the human gut microbiome.

Authors:  John W Pepper; Simon Rosenfeld
Journal:  Trends Ecol Evol       Date:  2012-04-25       Impact factor: 17.712

Review 2.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

Review 3.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

4.  Immunity to commensal skin fungi promotes psoriasiform skin inflammation.

Authors:  Charlotte Hurabielle; Verena M Link; Nicolas Bouladoux; Seong-Ji Han; Eric Dean Merrill; Yaima L Lightfoot; Nickie Seto; Christopher K E Bleck; Margery Smelkinson; Oliver J Harrison; Jonathan L Linehan; Samira Tamoutounour; Michail S Lionakis; Mariana J Kaplan; Saeko Nakajima; Yasmine Belkaid
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

Review 5.  Diet, genes, and microbes: complexities of colon cancer prevention.

Authors:  Diane F Birt; Gregory J Phillips
Journal:  Toxicol Pathol       Date:  2013-10-15       Impact factor: 1.902

6.  Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.

Authors:  Qing Wang; Kaicen Wang; Wenrui Wu; Longxian Lv; Xiaoyuan Bian; Liya Yang; Qiangqiang Wang; Yating Li; Jianzhong Ye; Daiqiong Fang; Jingjing Wu; Xianwan Jiang; Jiaojiao Xie; Yanmeng Lu; Lanjuan Li
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-04       Impact factor: 4.813

Review 7.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

Review 8.  NOD2 mutations and colorectal cancer - Where do we stand?

Authors:  Diogo Branquinho; Paulo Freire; Carlos Sofia
Journal:  World J Gastrointest Surg       Date:  2016-04-27

Review 9.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Authors:  Kristi Baker; Timo Rath; Magdalena B Flak; Janelle C Arthur; Zhangguo Chen; Jonathan N Glickman; Inti Zlobec; Eva Karamitopoulou; Matthew D Stachler; Robert D Odze; Wayne I Lencer; Christian Jobin; Richard S Blumberg
Journal:  Immunity       Date:  2013-11-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.